After HT treatment, there were apparent increases in serum ALT and AST levels in the TUS + MB + HT and MB + HT groups compared with those in the NS + HT and MB + sham groups as controls, and these elevated levels might signify liver damage from the treatment. The gene discussed is GPT; the disease is hematocrit.